跳至主要内容
临床试验/NCT07233564
NCT07233564进行中(未招募)不适用

Comparison of Pain Between Supraperiosteal Injection of Dexamethasone Versus Placebo on Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial

College of Physicians and Surgeons Pakistan1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2025年7月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
44
试验地点
1
主要终点
Post operative pain

研究概览

简要总结

This randomized controlled trial aims to compare the effectiveness of supra periosteal injection of dexamethasone versus placebo in reducing post operative pain in teeth diagnosed with symptomatic irreversible pulpitis. A total of 44 patients will be randomly assigned into two groups: Group A will receive a supra periosteal injection of dexamethasone(4mg/ml), and Group B will receive a similar injection of normal saline as placebo. post operative pain will be assessed at 6hr,24hr and 48hr using a VAS Analogue Scale, with the final outcome measured at 24hrs. the study will help determine whether local dexamethasone injection is effective in minimizing postoperative pain

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients age 18 or above 18 year old (to have complete apex formation)
  • Patient with normal periapical area (no pain on percussion).
  • Patient who have not received any preoperative analgesic and antibiotic in last one month.

排除标准

  • Pregnancy and Lactation because radiographs are contraindicated.
  • Moderate to severe periodontal disease because teeth are not salvageable.
  • Patient with nonvital teeth diagnose via cold test and EPT.
  • Patient with known sensitivity to dexamethasone by history.
  • Patients whose medical history include a history of certain illnesses, such as HIV, heart disease, or epilepsy (conditions that can affect a patient's rate of healing).

研究组 & 干预措施

Dexamethasone injection group

Experimental

participant in this arm will receive a supraperiosteal injection of 4mg/ml dexamethasone at the mucobuccal fold prior to endodontic treatment for symptomatic irreversible pulpitis

干预措施: Dexamathsone 4mg/ml associated with experimental arm (Drug)

Saline injector(placebo) group

Placebo Comparator

干预措施: Normal saline injection (Drug)

结局指标

主要结局

Post operative pain

时间窗: 24hr after endodontic treatment

Pain will be measured using a 10 - point Visual Analogue Scale where 0=no pain, 1-3=mild pain, 4-6= moderate pain, and 7-10 = severe pain the absence of pain will be considered as effective treatment

次要结局

未报告次要终点

研究者

发起方
College of Physicians and Surgeons Pakistan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aqsa Afzal

AAfzal

College of Physicians and Surgeons Pakistan

研究点 (1)

Loading locations...

相似试验